News for Providers
Top stories summarized by our editors
10/15/2018

Mediso Medical Imaging Systems and the National Physical Laboratory in the UK have entered a research collaboration that will enable NPL to use Mediso's AnyScan SPECT/CT/PET system in developing unique measurement abilities and provide the world's first triple-modality scanner directly calibrated using primary radioactivity standards. Mediso will apply the study's findings to its imaging products, said managing director Istvan Bagamery.

Full Story:
PharmaBiz (India)
10/15/2018

Israeli researchers found that bypassing agents used to treat hemophilia A patients, whether as a single or combination therapy, had the potential to become an alternative therapy option for pediatric hemophilia B patients with factor IX inhibitors, based on data from a nine-year follow-up study of three pediatric patients who did not experience severe adverse events or thrombosis throughout the study period after being treated with increasing concentrations of recombinant activated factor VII or factor VIII inhibitor bypassing activity. The findings were published in the journal Pediatric Blood & Cancer.

Full Story:
Hemophilia News Today
10/15/2018

Many hospitals located on the Florida panhandle evacuated their patients last week due to Hurricane Michael, although several of these stayed open to accept patients at their emergency departments, according to the Florida Agency for Health Care Administration. State emergency management officials reported that power outages and property damage also resulted in the evacuation of more than 30 health care facilities, including 14 nursing homes.

10/15/2018

The FDA sent letters to 21 e-cigarette manufacturers and importers seeking information on whether more than 40 products were being sold outside the FDA's compliance policy, and warning that illegally sold products will be taken off the market as part of an effort to curb e-cigarette use among youths. "We'll take forceful steps to stem the youth use, even if our actions have the unwelcome effect of impeding some opportunities for adults," said FDA Commissioner Scott Gottlieb.

More Summaries:
FDA, Scott Gottlieb
10/15/2018

Using soft tub margarine and reduced-fat cream cheese in the place of butter can cut the saturated fat content in cookie recipes, said registered dietitian Darlene Zimmerman. Peanut butter also can be used in place of margarine, Zimmerman said, and bakers can try reducing the sugar content of a recipe by one-eighth or one-quarter cup.

Full Story:
Detroit Free Press
More Summaries:
Darlene Zimmerman
10/15/2018

Decisive action against climate change is urgently needed to prevent a drastic increase in world hunger, according to officials with the World Food Programme. "We are projecting that with a two-degree warmer world, we will have around 189 million people in a status of food insecurity more than today," says Gernot Laganda, WFP's chief of Climate and Disaster Risk Reduction.

Full Story:
Voice of America
More Summaries:
WFP
10/12/2018

Support funding for medical and social services for persons living with HIV/AIDS from the US federal government have exceeded more than $2 billion in fiscal year 2018. More than $820 million went to states for the AIDS Drug Assistance Program, which provide medications to patients who are low-income and are underinsured or uninsured.

10/12/2018

Goats are becoming a common sight in West Sacramento, Calif., as people look to the ruminants to reduce wildfire hazards on their properties. Goats eat dry grass and debris that can fuel wildfires.

10/12/2018

Researchers found that women who had the highest levels in the normal range of prolactin, a breastfeeding-related hormone, were at a 27% reduced risk for type 2 diabetes, compared with those who had the lowest but still normal levels of the hormone. The findings in Diabetologia were based on more than 8,600 healthy US women.

Full Story:
HealthDay News
10/12/2018

Patients with type 1 diabetes who took empagliflozin significantly improved their glycemic control and reduced their weight without an increased rate of symptomatic or severe hypoglycemia, compared with those on placebo, according to a study presented at the European Association for the Study of Diabetes meeting and published in Diabetes Care. Researchers used a cohort of 1,707 patients from the EASE trials and found those who took the 10-mg and 25-mg doses of empagliflozin were up to four times more likely to develop diabetic ketoacidosis and genital infections, compared with the placebo group.

More Summaries:
Diabetic ketoacidosis